Eleva Capital SAS »

Mineralys Therapeutics shares owned by Eleva Capital SAS

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Eleva Capital SAS from 13F filings

Historical chart of Eleva Capital SAS investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Eleva Capital SAS consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Eleva Capital SAS

Quarter filed Position value Share count Share price at filing
2026-03-31 $463k 17k 27.09

More positions owned by Eleva Capital SAS

CRH Ord (CRH)
Amer Sports Com Shs (AS)
NVIDIA Corporation (NVDA)
Netflix (NFLX)
Alphabet Cap Stk Cl A (GOOGL)
Taiwan Semiconductor Mfg Lt Sponsored Ads (TSM)
Arista Networks Com Shs (ANET)
Amazon (AMZN)
Metropcs Communications (TMUS)
Robinhood Mkts Com Cl A (HOOD)
On Hldg Namen Akt A (ONON)
Boston Scientific Corporation (BSX)
Spotify Technology S A SHS (SPOT)
Newamsterdam Pharma Company Ordinary Shares (NAMS)
Cg Oncology (CGON)

View all positions for Eleva Capital SAS

Top funds holding Mineralys Therapeutics

Catalys Pacific
RA Capital Management
Samsara BioCapital
Caligan Partners
FMR
BlackRock
Vanguard Group
State Street Corporation
Caption Management
Franklin Resources
Laurion Capital Management
Boothbay Fund Management
Holocene Advisors
Sr One Capital Management
Suvretta Capital Management

View all funds holding Mineralys Therapeutics